Countable Labs announces Ancora assays for molecular testing of hematologic malignancy, marking the company's entry into clinical markets.
Countable Labs has raised $26m to advance the development and commercialisation activities for its single-molecule polymerase chain reaction (PCR) technology. The California-based company’s financing ...
Bio-Rad Laboratories (NYSE:BIO) is pursuing a multi-year effort to improve growth, expand margins and strengthen free cash ...
Stilla Technologies, a leader in multiplex digital PCR technology, proudly announces the addition of two new digital PCR system configurations to the Nio™ product line, which debuted in November 2023 ...
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 ...
Digital PCR (dPCR) is the third generation of PCR technology, after conventional PCR and real-time quantitative PCR. It offers significant benefits over these other methods, making it ideal for a wide ...
DUBLIN, Jan. 9, 2024-- The "Polymerase Chain Reaction (PCR) Technologies and Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global market for quantitative ...
Hello, and welcome to our next deep dive. Today, it's all about QIAcuity digital PCR. We're going to answer questions around what is digital PCR, how does it compare with quantitative PCR and how does ...
We will discuss the Digital LightCycler System, a digital PCR (dPCR) system for DNA and RNA with 6-color capability for flexible, multiplexed biomarker detection. With advances in sensitivity, ...
PCR, or Polymerase Chain Reaction, is a revolutionary molecular biology technique that allows for the rapid amplification of specific DNA sequences. It is an essential tool in various fields, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results